- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00944762
Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors
Ecosystem Focused Therapy for Depressed Stroke Survivors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A stroke occurs when blood cannot reach part of the brain, either because of a blocked blood vessel (ischemic stroke) or because of a burst blood vessel (hemorrhagic stroke). When a part of the brain is deprived of blood, brain cells in that part often die or are at risk of dying. In addition to physical difficulties, older adults who survive strokes can also suffer from depression and cognitive dysfunction. Effective psychotherapy treatments that provide rehabilitation for problems in emotions and thinking are still needed. Ecosystem focused therapy (EFT) is a specialized psychotherapy that helps patients learn problem-solving skills and make adjustments in their environment. This study will determine the effectiveness of EFT in reducing depression and improving functioning and quality of life in older adults who experienced an ischemic stroke and are now depressed.
Participation in this study will last 1 year. Participants will be randomly assigned to receive one of two treatments: EFT or education in stroke and depression (ESD). Both treatments will be led by therapists and will involve 12 sessions over 25 weeks, with sessions occurring weekly for the first month, every other week for the second 2 months, and monthly for the last 3 months. EFT will involve the following: teaching the participant skills for solving problems related to adjusting to a stroke, altering the participant's physical environment to accommodate new needs, and helping the family or caregiver to assist in the participant's adaptation. ESD will involve providing the participant with education on living with a stroke and depression. Study assessments will include interviews and will occur at nine time points: at baseline and after 2, 3, 6, 10, 14, 20, 26, and 52 weeks. These assessments will measure participants' mood, thinking, and functioning. A family member or caregiver of the older adult participant must also be able to participate in the study, in order both to complete assessments and effectively implement EFT.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
White Plains, New York, United States, 10605
- The Burke Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of unipolar major or minor depression, as assessed by the Structured Clinical Interview for Depression (SCID) for the Diagnostic and Statistical Manual-IV
- Montgomery-Asberg Depression Rating Scale (MADRS) score greater than or equal to 15
- Admitted to Burke Rehabilitation Hospital soon after ischemic stroke
- Mini Mental State Examination (MMSE) score greater than 17
- Command of English sufficient to comprehend study questionnaires and interventions
- Has family member or professional caregiver willing and able to participate in patient's treatment
Exclusion Criteria:
- Moderately severe to severe dementia, as defined by an MMSE score less than 17
- Moderate to severe aphasia
- Placed in a nursing home after discharge
- Diagnosis of psychotic depression
- High suicide risk (i.e., intent or plan to attempt suicide in near future)
- Presence of illnesses other than stroke (e.g., untreated thyroid or adrenal disease, pancreatic cancer, and lymphoma)
- Taking drugs known to cause depression (e.g., reserpine, alpha-methyl-dopa, steroids)
- Currently being treated for depression with psychotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ecosystem Focused Therapy (EFT)
Participants will receive EFT.
|
12 therapist-led sessions over 25 weeks, in which a participant will learn problem-solving skills, the participant's physical environment will be modified, and the family or caregiver will facilitate the participant's adaptation.
Active participation in treatment and rehabilitation for stroke will also be targeted by EFT's problem-solving approach, creating synergy among treatments.
|
Active Comparator: Education in stroke and depression
Participants will receive education in stroke and depression.
|
Information and resources on living with stroke and depression will be provided in 12 sessions over 25 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Depression
Time Frame: Measured at baseline and after 2, 3, 6, 10, 14, 20, 26, and 52 weeks
|
Measured at baseline and after 2, 3, 6, 10, 14, 20, 26, and 52 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Disability
Time Frame: Measured at baseline and after 2, 3, 6, 10, 14, 20, 26, and 52 weeks
|
Measured at baseline and after 2, 3, 6, 10, 14, 20, 26, and 52 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Victoria Wilkins, PhD, Weill Medical College of Cornell University
- Study Director: George S. Alexopoulos, MD, Weill Medical College of Cornell University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0811010074
- P30MH085943 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Lawson Health Research InstituteTerminated
Clinical Trials on Ecosystem Focused Therapy (EFT)
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed
-
Islamic Azad University, Najafabad BranchCompletedFunctional Gastrointestinal Disorders
-
Institutt for Psykologisk RadgivningUniversity of BergenActive, not recruiting
-
Instituto Portugues de Oncologia, Francisco Gentil...Linnaeus University; University of Oulu; European Commission; Polytechnic Institute... and other collaboratorsUnknown
-
University of BernCompletedUnipolar Depression | Adjustment Disorder | Anxiety DisorderSwitzerland
-
Istanbul Saglik Bilimleri UniversityCompleted
-
Soul Medicine InstituteRecruitingPost-Traumatic Stress DisordersUnited States
-
Soul Medicine InstituteRecruiting
-
University of South CarolinaMedical University of South Carolina; National Institute on Deafness and Other...RecruitingStroke | Aphasia | Stroke RehabilitationUnited States
-
University of BaselUniversity of ZurichRecruitingMotivation | Alliance, TherapeuticSwitzerland